Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseqTM) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Treatment With Hepcludex® (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks
Gilead Sciences, Inc. (Nasdaq: GILD) today announced Week 48 results from the Pivotal Phase 3 […]
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
BioNTech SE (Nasdaq: BNTX, “BioNTech”) has reached the next milestone in the establishment of scalable mRNA […]
Targovax Announces That the FDA Has Granted Authorization to Initiate Clinical Trials With the Enhanced TG01 RAS Vaccine in the USA
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced […]
BioMech, ēlizur Announce Partnership Integrating AI-enabled Motion Analytics into Physical Therapy Solution
BioMech Health, a division of BioMech Holdings, LLC, and ēlizur, a leading musculoskeletal solutions provider, announced today a […]
FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell […]
Carthera Receives FDA Breakthrough Device Designation for SonoCloud-9 System
Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
Naobios Delivers Flugen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more